CompaniesByCap
IKT
Inhibikase Therapeutics Inc. (IKT)
NASDAQ · Healthcare

Inhibikase Therapeutics Inc. Price to FCF Ratio 2020–2026

Price to free cash flow (P/FCF) ratio for Inhibikase Therapeutics Inc. (IKT): market cap divided by trailing twelve-month free cash flow. As of it is —.
From: 03/31/2021To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF

Inhibikase Therapeutics Inc. Price to FCF Ratio — FAQ

Inhibikase Therapeutics Inc. (IKT) price to fcf ratio over the last 5 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see IKT's price to fcf ratio history?

The chart and table above show Inhibikase Therapeutics Inc.'s price to fcf ratio by year and by quarter, including the growth rate.